(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

FedEx and KB Home's Earnings: A Tale of Contrasting Reactions

September 20th, 2023

FedEx Corporation (NYSE: FDX), a renowned global courier delivery services company, reported first-quarter fiscal 2024 earnings of $4.55 per share, surpassing the consensus EPS estimate of $3.73. The company's quarterly revenues amounted to $21.70 bi. Read more

Market Buzz: General Mills Beats Estimates; Bullish View on IBM

September 20th, 2023

General Mills, Inc. (NYSE: GIS), a notable food products manufacturer, reported first-quarter fiscal 2024 adjusted earnings of $1.09 per share, surpassing the consensus EPS estimate of $1.08. Additionally, its quarterly sales amounted to $4.90 billio. Read more

Pre-market Shock: ARS Pharmaceuticals Faces Setback

September 20th, 2023

Shares of ARS Pharmaceuticals, Inc. (Nasdaq: SPRY) plunged over 40% following the announcement that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for neffy (epinephrine na. Read more

Israeli Court's Determination Boosts Nano Dimension; Steelcase Outperforms Estimates

September 19th, 2023

Shares of Nano Dimension Ltd. (Nasdaq: NNDM) surged over 5% in after-hours trading following the company's announcement of receiving Israeli court approval to extend its share repurchase plan. The plan, originally approved by the Israeli court in Aug. Read more

Clorox Faces Cybersecurity Attack; Steel Dynamics Guides Below-Consensus Profits

September 18th, 2023

Shares of The Clorox Company (NYSE: CLX) experienced a pre-market decline following the company's disclosure in an SEC regulatory filing regarding unauthorized activity detected on certain Information Technology systems. The cybersecurity attack is d. Read more

1847 Seeks Strategic Alternatives; Bullish Stance On L3Harris

September 18th, 2023

Shares of 1847 Holdings LLC (NYSE American: EFSH) surged by more than 5% in pre-market trading following the company's announcement of engaging Spartan Capital Securities LLC to explore strategic alternatives geared towards boosting shareholder value. Read more

FedEx, General Mills, and KB Home's Earnings Preview: Key Metrics

September 17th, 2023

On Wednesday, September 20, a lineup of companies is slated to announce their financial results, including: FedEx Corp. (NYSE: FDX), a global courier giant, is set to unveil its first-quarter fiscal 2024 financial results after the market's closin. Read more

Earnings in Focus: AutoZone, Endava , and Apogee Enterprises Gear Up

September 16th, 2023

On Tuesday, September 19, several companies are scheduled to announce their financial results, including: AutoZone, Inc. (NYSE: AZO), a leading auto parts retailer, is set to announce fourth-quarter results for the period ending August 26, 2023, b. Read more

President Biden: Auto Workers Deserve Fair Compensation

September 15th, 2023

President Joe Biden addressed the ongoing auto strike and contract negotiations between the United Auto Workers (UAW) and the Big 3 auto companies: Ford Motor Company (NYSE: F), General Motors Company (NYSE: GM), and Stellantis N.V. (NYSE: STLA). He . Read more

PDUFA Extension Fuels Iovance Biotherapeutics; PTC Therapeutics Faces Setback

September 15th, 2023

Shares of Iovance Biotherapeutics, Inc. (Nasdaq: IOVA) surged over 10% after the U.S. Food and Drug Administration (FDA) extended the Prescription Drug User Fee Act (PDUFA) for lifileucel due to resource constraints. The new target action date is . Read more